Release Date: 28/01/20 08:20 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 353.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%